Steven Valiquette
Stock Analyst at Mizuho
(3.42)
# 1,036
Out of 4,981 analysts
111
Total ratings
56.9%
Success rate
2.81%
Average return
Main Sectors:
Stocks Rated by Steven Valiquette
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| VEEV Veeva Systems | Maintains: Outperform | $295 → $325 | $276.43 | +17.57% | 4 | Aug 29, 2025 | |
| PHR Phreesia | Initiates: Outperform | $36 | $24.19 | +48.82% | 1 | Aug 27, 2025 | |
| NVST Envista Holdings | Maintains: Underperform | $15 → $18 | $21.01 | -14.33% | 2 | Aug 1, 2025 | |
| TDOC Teladoc Health | Initiates: Neutral | $10 | $7.68 | +30.21% | 1 | Jul 25, 2025 | |
| WAY Waystar Holding | Initiates: Outperform | $48 | $37.36 | +28.48% | 1 | Jun 30, 2025 | |
| DOCS Doximity | Maintains: Neutral | $65 → $60 | $71.03 | -15.53% | 3 | May 16, 2025 | |
| ALGN Align Technology | Maintains: Outperform | $250 → $245 | $131.56 | +86.23% | 11 | Apr 29, 2025 | |
| MCK McKesson | Maintains: Neutral | $630 → $690 | $711.42 | -3.01% | 3 | Apr 3, 2025 | |
| CAH Cardinal Health | Maintains: Outperform | $142 → $150 | $152.24 | -1.47% | 6 | Mar 31, 2025 | |
| XRAY DENTSPLY SIRONA | Maintains: Neutral | $21 → $18 | $13.54 | +32.99% | 7 | Mar 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $70 → $82 | $73.39 | +11.73% | 2 | Mar 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $7 | $5.80 | +20.69% | 1 | Dec 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $126 | $92.49 | +36.23% | 1 | Dec 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $75 | $69.01 | +8.68% | 5 | Dec 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $5 | $2.56 | +95.31% | 1 | Dec 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $18 → $14 | $5.34 | +162.17% | 7 | Nov 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $142 | $191.72 | -25.93% | 10 | Sep 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $55 | $69.73 | -21.12% | 6 | Aug 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $82 → $92 | $169.13 | -45.60% | 10 | Aug 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $565 | $352.51 | +60.28% | 5 | Apr 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $110 → $100 | $74.98 | +33.37% | 1 | Mar 30, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $17 → $14 | $5.13 | +172.90% | 1 | Feb 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $380 → $400 | $180.88 | +121.14% | 4 | Oct 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reinstates: Overweight | $107 | $33.26 | +221.71% | 1 | Jul 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Equal-Weight | $22 → $17 | $34.20 | -50.29% | 3 | Apr 18, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $5 → $12 | $7.51 | +59.79% | 1 | Jun 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $96 | $126.05 | -23.84% | 3 | Nov 23, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | $105 → $120 | $182.91 | -34.39% | 6 | Apr 30, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $117 → $127 | $405.13 | -68.65% | 1 | Apr 22, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $327 → $358 | $276.44 | +29.50% | 3 | Dec 6, 2019 |
Veeva Systems
Aug 29, 2025
Maintains: Outperform
Price Target: $295 → $325
Current: $276.43
Upside: +17.57%
Phreesia
Aug 27, 2025
Initiates: Outperform
Price Target: $36
Current: $24.19
Upside: +48.82%
Envista Holdings
Aug 1, 2025
Maintains: Underperform
Price Target: $15 → $18
Current: $21.01
Upside: -14.33%
Teladoc Health
Jul 25, 2025
Initiates: Neutral
Price Target: $10
Current: $7.68
Upside: +30.21%
Waystar Holding
Jun 30, 2025
Initiates: Outperform
Price Target: $48
Current: $37.36
Upside: +28.48%
Doximity
May 16, 2025
Maintains: Neutral
Price Target: $65 → $60
Current: $71.03
Upside: -15.53%
Align Technology
Apr 29, 2025
Maintains: Outperform
Price Target: $250 → $245
Current: $131.56
Upside: +86.23%
McKesson
Apr 3, 2025
Maintains: Neutral
Price Target: $630 → $690
Current: $711.42
Upside: -3.01%
Cardinal Health
Mar 31, 2025
Maintains: Outperform
Price Target: $142 → $150
Current: $152.24
Upside: -1.47%
DENTSPLY SIRONA
Mar 13, 2025
Maintains: Neutral
Price Target: $21 → $18
Current: $13.54
Upside: +32.99%
Mar 3, 2025
Maintains: Neutral
Price Target: $70 → $82
Current: $73.39
Upside: +11.73%
Dec 4, 2024
Initiates: Neutral
Price Target: $7
Current: $5.80
Upside: +20.69%
Dec 4, 2024
Initiates: Outperform
Price Target: $126
Current: $92.49
Upside: +36.23%
Dec 4, 2024
Initiates: Neutral
Price Target: $75
Current: $69.01
Upside: +8.68%
Dec 4, 2024
Initiates: Outperform
Price Target: $5
Current: $2.56
Upside: +95.31%
Nov 5, 2024
Maintains: Equal-Weight
Price Target: $18 → $14
Current: $5.34
Upside: +162.17%
Sep 21, 2023
Maintains: Equal-Weight
Price Target: $142
Current: $191.72
Upside: -25.93%
Aug 4, 2023
Maintains: Overweight
Price Target: $55
Current: $69.73
Upside: -21.12%
Aug 2, 2023
Maintains: Overweight
Price Target: $82 → $92
Current: $169.13
Upside: -45.60%
Apr 14, 2023
Maintains: Overweight
Price Target: $565
Current: $352.51
Upside: +60.28%
Mar 30, 2023
Maintains: Overweight
Price Target: $110 → $100
Current: $74.98
Upside: +33.37%
Feb 27, 2023
Maintains: Overweight
Price Target: $17 → $14
Current: $5.13
Upside: +172.90%
Oct 28, 2022
Maintains: Overweight
Price Target: $380 → $400
Current: $180.88
Upside: +121.14%
Jul 28, 2022
Reinstates: Overweight
Price Target: $107
Current: $33.26
Upside: +221.71%
Apr 18, 2022
Downgrades: Equal-Weight
Price Target: $22 → $17
Current: $34.20
Upside: -50.29%
Jun 11, 2021
Upgrades: Overweight
Price Target: $5 → $12
Current: $7.51
Upside: +59.79%
Nov 23, 2020
Upgrades: Overweight
Price Target: $96
Current: $126.05
Upside: -23.84%
Apr 30, 2020
Reiterates: Neutral
Price Target: $105 → $120
Current: $182.91
Upside: -34.39%
Apr 22, 2020
Maintains: Overweight
Price Target: $117 → $127
Current: $405.13
Upside: -68.65%
Dec 6, 2019
Maintains: Overweight
Price Target: $327 → $358
Current: $276.44
Upside: +29.50%